000			02320 a2200661 4500
005			20250517002041.0
264		0	_c20150604
008			201506s 0 0 eng d
022			_a1476-5551
024	7		_a10.1038/leu.2014.320 _2doi
040			_aNLM _beng _cNLM
100	1		_aHuelsemann, M F
245	0	0	_aHypoxia-induced p38 MAPK activation reduces Mcl-1 expression and facilitates sensitivity towards BH3 mimetics in chronic lymphocytic leukemia. _h[electronic resource]
260			_bLeukemia _cApr 2015
300			_a981-4 p. _bdigital
500			_aPublication Type: Letter; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aB-Lymphocytes _xdrug effects
650	0	4	_aBendamustine Hydrochloride
650	0	4	_aBiphenyl Compounds _xpharmacology
650	0	4	_aBridged Bicyclo Compounds, Heterocyclic _xpharmacology
650	0	4	_aCD40 Ligand _xgenetics
650	0	4	_aCell Hypoxia
650	0	4	_aCells, Cultured
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aEnzyme Activation
650	0	4	_aGene Expression Regulation, Leukemic
650	0	4	_aHumans
650	0	4	_aLeukemia, Lymphocytic, Chronic, B-Cell _xgenetics
650	0	4	_aMyeloid Cell Leukemia Sequence 1 Protein _xantagonists & inhibitors
650	0	4	_aNitrogen Mustard Compounds _xpharmacology
650	0	4	_aNitrophenols _xpharmacology
650	0	4	_aOxygen _xpharmacology
650	0	4	_aPiperazines _xpharmacology
650	0	4	_aProto-Oncogene Proteins c-bcl-2 _xgenetics
650	0	4	_aSignal Transduction
650	0	4	_aSulfonamides _xpharmacology
650	0	4	_aVidarabine _xanalogs & derivatives
650	0	4	_abcl-X Protein _xgenetics
650	0	4	_ap38 Mitogen-Activated Protein Kinases _xgenetics
700	1		_aPatz, M
700	1		_aBeckmann, L
700	1		_aBrinkmann, K
700	1		_aOtto, T
700	1		_aFandrey, J
700	1		_aBecker, H J
700	1		_aTheurich, S
700	1		_avon Bergwelt-Baildon, M
700	1		_aPallasch, C P
700	1		_aZahedi, R P
700	1		_aKashkar, H
700	1		_aReinhardt, H C
700	1		_aHallek, M
700	1		_aWendtner, C M
700	1		_aFrenzel, L P
773	0		_tLeukemia _gvol. 29 _gno. 4 _gp. 981-4
856	4	0	_uhttps://doi.org/10.1038/leu.2014.320 _zAvailable from publisher's website
999			_c24334914 _d24334914